Stock CYBN CYBIN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cybin Inc.

Equities

CYBN

CA23256X1006

Market Closed - Nyse
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
0.37 USD +0.27% Intraday chart for Cybin Inc. +5.71% -9.76%
05-06 Cybin Provides Corporate Provides Update Highlighting Recent Clinical Accomplishments and Key Upcoming Catalysts Across Its Development Pipeline CI
04-17 Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003 MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Cybin Price Target to $5 From $10, Maintains Buy Rating
MT
Oppenheimer Adjusts Cybin Price Target to $4 From $4.50, Maintains Outperform Rating
MT
Canaccord Genuity Adjusts Price Target on Cybin to $5 From $6, Maintains Buy Rating
MT
Stifel Nicolaus Adjusts Cybin's Price Target to $1.13 From $1.10, Maintains Speculative Buy Rating
MT
Canaccord Genuity Trims Price Target on Cybin to $6 From $7, Maintains Buy Rating
MT
EF Hutton Initiates Cybin at Buy With $3 Price Target
MT
Stifel Nicolaus Adjusts Cybin Price Target to CA$3 From CA$8.25, Maintains Speculative Buy Rating
MT
Stifel Nicolaus Adjusts Cybin PT to CA$8.25 From CA$10, Maintains Speculative Buy Rating
MT
HC Wainwright Adjusts Cybin's Price Target to $10 From $8, Reiterates Buy Rating
MT
CYBIN : Oppenheimer Initiates Coverage on Cybin With Outperform Rating, $7 Price Target
MT
CYBIN : Canaccord Genuity Adjusts Cybin's Price Target to $7 From $6, Reiterates Buy Rating
MT
CYBIN : Cantor Fitzgerald Starts Cybin at Overweight with $9 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYBN Stock
  4. News Cybin Inc.
  5. Analyst Reco.